Weysen, Gangnam Jin Hospital and 'Waymed Endo' Supply Contract Signed

AI medtech specialist Weixen announced on the 11th that it signed a supply contract with Gangnam Jiin Hospital for the artificial intelligence endoscopy solution 'WAIMed Endo'.

This contract was promoted with the purpose of introducing AI-based endoscopic technology to detect digestive cancers early during health checkups and increase the possibility of early treatment. Gangnam Jin Hospital is a hospital with various treatment capabilities in the field of digestive endoscopy, including health checkups, polypectomy, and endoscopic resection (ESD) of early gastric cancer and colon cancer, and provides precision treatment based on skilled medical staff and cutting-edge equipment.

In particular, the hospital has continuously received 'Excellent Endoscopy Room Certification' from the Korean Society of Gastrointestinal Endoscopy and the Endoscopy Research Foundation since 2019, and is also highly regarded for its reliability in terms of endoscopy examination quality and safety.

Gangnam Jin Hospital has also built an innovative treatment environment through continuous technology introduction in the field of medical artificial intelligence. It has applied various AI-based diagnostic solutions, including diagnosing chest diseases, to actual clinical practice, and the introduction of 'Waymed Endo' was also decided after a multi-faceted evaluation process.

'Waymed Endo' is an artificial intelligence software medical device that is linked to a digestive endoscope to detect lesions in real time and provide immediate notifications to medical staff. According to Waysen, medical staff using the solution at Gangnam Jiin Hospital are giving positive evaluations on the accuracy of detecting abnormal lesions and the improvement in examination efficiency.

Waymed Endo CEO Kim Kyung-nam said, “The introduction of AI endoscopy solutions will enable more precise and safer endoscopic examinations,” and added, “In particular, as the incidence of colon cancer is increasing, Waymed Endo will continue to work on product advancements so that it can contribute to creating a high-quality endoscopic diagnostic environment.”

Director Won-Young Cho of Gangnam Jin Hospital said, “As a hospital specializing in digestive diseases, we expect that by incorporating artificial intelligence technology, we will be able to perform more precise screening tests,” and “We will actively utilize Waymed Endo to contribute to the promotion of digestive health and early diagnosis of cancer in patients.”


  • See more related articles